The company have significantly boosted the course of the new treatment for cardiac amyloidosis, utilizing the compound. Preliminary trial results suggests potential outcomes for those diagnosed from the debilitating https://attruby582880.idblogz.com/42466174/bridgebio-progresses-amyloidosis-therapy-through-the-drug